ARCHIVES

In Brief: No Decision Yet On How CALB Cuts Will Be Made; Wyngaarden Of Duke Will Be New Director of NIH

This article is from The Cancer Letter archive.

Vol. 08 No. 05 | January 29, 1982

Download PDF Visit The Full Archive

Related Articles

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

FDA Approves New Drug for Advanced Kidney Cancer

May 25, 2007

CMS Withholds Coverage of CT Colonography

May 15, 2009

Niederhuber Leads AACI

November 2, 2001

Cooperative Groups Pursue Contracts With Insurers, NCI Warns of Competition

June 14, 1996

Stop Cancer Foundation’s Future In Question, May Not Deliver All Of Funds Promised to NCI

January 18, 1991